Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value
$349.88+1.17 (+0.34%)
Close on Nov 11, 2026Market cap $66.77BP/E 26.0Yield 0.63%
Cencora EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Cencora's EV/EBITDA was 18.6× on Nov 11, 2026, against 20.4× a year earlier. Over the last 5 years it ranged from 12.7× to 30.0×, with a median of 18.4×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 18.6× | −0.2 |
| 2025 | Dec 31, 2025 | 18.8× | −2.0 |
| 2024 | Dec 31, 2024 | 20.8× | +2.2 |
| 2023 | Dec 29, 2023 | 18.6× | +3.1 |
| 2022 | Dec 30, 2022 | 15.5× | +1.9 |
| 2021 | Dec 31, 2021 | 13.7× | −4.0 |
| 2020 | Oct 30, 2020 | 17.6× | +1.0 |
| 2019 | Dec 31, 2019 | 16.6× | +4.3 |
| 2018 | Dec 31, 2018 | 12.3× | −7.5 |
| 2017 | Dec 29, 2017 | 19.8× | +7.6 |
| 2016 | Dec 30, 2016 | 12.2× | −41.7 |
| 2015 | Dec 31, 2015 | 54.0× | +28.1 |
| 2014 | Dec 31, 2014 | 25.8× | +7.6 |
| 2013 | Dec 31, 2013 | 18.2× | +10.1 |
| 2012 | Dec 31, 2012 | 8.0× | +0.3 |
| 2011 | Dec 30, 2011 | 7.8× | −0.6 |
| 2010 | Dec 31, 2010 | 8.4× | −0.3 |
| 2009 | Dec 31, 2009 | 8.7× | – |
See a number that looks wrong?